Meditation App for Mental Health

Age: < 65

Sex: Any

Trial Phase: Academic

Sponsor: University of Illinois at Chicago

Disqualifiers: Detained, Non-English speaking, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: 4 weeks

300 Participants Needed

Trial Summary

What is the purpose of this trial?

The goals of this hybrid type 2 randomized controlled trial (RCT) are to evaluate the effectiveness and individual-level implementation of a 1-month app-based meditation program with youth on probation in Cook County, IL. The primary questions it is designed to answer are: 1. Is the meditation app associated with improvements in behavioral health outcomes including cannabis use problems? 2. Do improvements in emotion regulation appear to mediate the effects of the meditation app on these behavioral health outcomes? 3. Will youth adequately adhere to the meditation app?

Eligibility Criteria

This trial is for English-speaking youth aged 13-20 in Cook County's probation programming who have access to a smartphone and can understand and provide consent. Parental consent is required for those under 18.

Inclusion Criteria

I understand the study and agree to participate.

Have access to an Apple/Android smartphone

I am between 13 and 20 years old.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use either the meditation app or an active control app daily for 30 days

4 weeks

Remote participation

Follow-up

Participants are monitored for behavioral health outcomes and app adherence

6 months

Self-reported assessments at baseline, 1 month, and 6 months

Treatment Details

Interventions

• Bodhi AIM

Trial Overview The study tests an app-based meditation program, Bodhi AIM, against a control group using HIB. It aims to see if the app improves behavioral health outcomes like cannabis use problems and emotion regulation among these youths.

Participant Groups

Group I: Bodhi AIM Experimental Treatment 1 Intervention

Participants randomized to the intervention arm will receive the Bodhi AIM meditation app.

Group II: HIB Active Control 1 Intervention

Participants randomized to the active control arm will receive the HIB health promotion app.

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials

653

Recruited

1,574,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials

2,658

Recruited

3,409,000+